fluorobenzenes has been researched along with Neuralgia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bachand, K; Boudreau, D; De Koninck, Y; Doyon, N; Ferrini, F; Gagnon, M; Girard, AA; Godin, AG; Kianicka, I; Labrecque, S; Lorenzo, LE; Plasencia-Fernandez, I; Ribeiro-da-Silva, A | 1 |
| Aoki, Y; Hattori, M; Horikawa, H; Ito, H; Takemura, Y; Yamazaki, M | 1 |
| Dong, LY; Liu, HJ; Liu, YN; Niu, HL; Shao, LM; Wang, J; Wang, K; Xue, DQ; Zheng, YL; Zou, AR | 1 |
| Liang, X; Su, R; Yu, G | 1 |
| Ji, Q; Li, W; Li, Y; Liu, J; Shu, Y; Zhang, L; Zhu, S | 1 |
| Duggan, PJ; Gleeson, EC; Graham, JE; Lewis, RJ; Spiller, S; Tuck, KL; Vetter, I | 1 |
| Chen, M; Yang, Y | 1 |
| Zhang, J | 1 |
| Blech-Hermoni, Y; Faravelli, L; Seltzer, Z; Zhang, SH | 1 |
| Lee, S; Lim, TKY; Shi, XQ; Zhang, J; Zhao, YQ | 1 |
| Goldstein, MR; Grant, WB; Mascitelli, L | 1 |
11 other study(ies) available for fluorobenzenes and Neuralgia
| Article | Year |
|---|---|
Enhancing neuronal chloride extrusion rescues α2/α3 GABA
Topics: Analgesia; Analgesics; Animals; Brain-Derived Neurotrophic Factor; Chlorides; Disease Models, Animal; Fluorobenzenes; GABA-A Receptor Agonists; Ion Transport; K Cl- Cotransporters; Ligands; Male; Neuralgia; Neurons; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, GABA-A; Symporters; Synapses; Triazoles | 2020 |
Analysis of the effects of a tricyclic antidepressant on secondary sleep disturbance induced by chronic pain in a preclinical model.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Chronic Pain; Disease Models, Animal; Fluorobenzenes; Male; Mice; Neuralgia; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders | 2020 |
Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.
Topics: Action Potentials; Analgesics; Animals; Fluorobenzenes; Formaldehyde; Ganglia, Spinal; Guinea Pigs; HEK293 Cells; Humans; Inflammation; Male; Mice, Inbred C57BL; NAV1.7 Voltage-Gated Sodium Channel; Neuralgia; Neurons; Spinal Nerves; Voltage-Gated Sodium Channel Blockers | 2021 |
Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain.
Topics: Amines; Analgesics; Animals; Antineoplastic Agents; Blood Pressure; Cyclohexanecarboxylic Acids; Disease Models, Animal; Fluorobenzenes; Gabapentin; gamma-Aminobutyric Acid; Heart Rate; Locomotion; Male; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System; Rats; Rats, Sprague-Dawley | 2018 |
Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44.
Topics: Analgesics, Opioid; Animals; Astrocytes; Drug Interactions; Drug Tolerance; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fluorobenzenes; Glial Fibrillary Acidic Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Male; Morphine; Neuralgia; Phosphorylation; Pyrimidines; Rats, Sprague-Dawley; Rosuvastatin Calcium; Spinal Cord Injuries; Spinal Nerves; Sulfonamides; Tumor Necrosis Factor-alpha | 2015 |
Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives.
Topics: Analgesics, Non-Narcotic; Anilides; Binding, Competitive; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium Signaling; Cell Line, Tumor; Drug Design; Fluorobenzenes; High-Throughput Screening Assays; Humans; Molecular Structure; Molecular Targeted Therapy; Nerve Tissue Proteins; Neuralgia; Neurons; Neurotoxins; omega-Conotoxin GVIA; Pain, Intractable; Structure-Activity Relationship | 2015 |
Statistical analysis regarding: statins alleviate experimental nerve injury-induced neuropathic pain.
Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neuralgia; Pyrimidines; Simvastatin; Sulfonamides | 2015 |
Reply to "Statistical analysis regarding: statins alleviate experimental nerve injury-induced neuropathic pain".
Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neuralgia; Pyrimidines; Simvastatin; Sulfonamides | 2015 |
Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat.
Topics: Administration, Oral; Analgesics; Animals; Behavior, Animal; Fluorobenzenes; Hindlimb; Neuralgia; Pain Measurement; Pain Threshold; Pain, Postoperative; Premedication; Rats | 2008 |
Statins alleviate experimental nerve injury-induced neuropathic pain.
Topics: Analysis of Variance; Animals; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorobenzenes; Functional Laterality; Glial Fibrillary Acidic Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperalgesia; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Microglia; Neuralgia; Pain Measurement; Pain Threshold; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2011 |
Statins, vitamin D, and neuropathic pain.
Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neuralgia; Pyrimidines; Simvastatin; Sulfonamides | 2011 |